205 related articles for article (PubMed ID: 25500427)
1. Immunosuppressive mediators of oral squamous cell carcinoma in tumour samples and saliva.
Gonçalves AS; Arantes DA; Bernardes VF; Jaeger F; Silva JM; Silva TA; Aguiar MC; Batista AC
Hum Immunol; 2015 Jan; 76(1):52-8. PubMed ID: 25500427
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of immunomodulatory mediators in oral precancerous lesions.
Gonçalves AS; Mosconi C; Jaeger F; Wastowski IJ; Aguiar MCF; Silva TA; Ribeiro-Rotta RF; Costa NL; Batista AC
Hum Immunol; 2017 Nov; 78(11-12):752-757. PubMed ID: 28941745
[TBL] [Abstract][Full Text] [Related]
3. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
4. Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients.
Aziz S; Ahmed SS; Ali A; Khan FA; Zulfiqar G; Iqbal J; Khan AA; Shoaib M
Cancer Invest; 2015; 33(7):318-28. PubMed ID: 26046681
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 beta in unstimulated whole saliva is a potential biomarker for oral squamous cell carcinoma.
Kamatani T; Shiogama S; Yoshihama Y; Kondo S; Shirota T; Shintani S
Cytokine; 2013 Nov; 64(2):497-502. PubMed ID: 24063998
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma.
Rhodus NL; Ho V; Miller CS; Myers S; Ondrey F
Cancer Detect Prev; 2005; 29(1):42-5. PubMed ID: 15734216
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical Expression of CD105 and TGF-β1 in Oral Squamous Cell Carcinoma and Adjacent Apparently Normal Oral Mucosa and its Correlation With Clinicopathologic Features.
Nair S; Nayak R; Bhat K; Kotrashetti VS; Babji D
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):35-41. PubMed ID: 25710582
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma.
St John MA; Li Y; Zhou X; Denny P; Ho CM; Montemagno C; Shi W; Qi F; Wu B; Sinha U; Jordan R; Wolinsky L; Park NH; Liu H; Abemayor E; Wong DT
Arch Otolaryngol Head Neck Surg; 2004 Aug; 130(8):929-35. PubMed ID: 15313862
[TBL] [Abstract][Full Text] [Related]
9. Validation of the diagnostic utility of salivary interleukin 8 in the differentiation of potentially malignant oral lesions and oral squamous cell carcinoma in a region with high endemicity.
Rajkumar K; Nandhini G; Ramya R; Rajashree P; Kumar AR; Anandan SN
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Sep; 118(3):309-19. PubMed ID: 24950604
[TBL] [Abstract][Full Text] [Related]
10. EGF in saliva and tumor samples of oral squamous cell carcinoma.
Bernardes VF; Gleber-Netto FO; Sousa SF; Silva TA; Abreu MH; Aguiar MC
Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):528-33. PubMed ID: 21436680
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated macrophages and the profile of inflammatory cytokines in oral squamous cell carcinoma.
Costa NL; Valadares MC; Souza PP; Mendonça EF; Oliveira JC; Silva TA; Batista AC
Oral Oncol; 2013 Mar; 49(3):216-23. PubMed ID: 23089461
[TBL] [Abstract][Full Text] [Related]
12. Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma.
Wu CC; Chang YT; Chang KP; Liu YL; Liu HP; Lee IL; Yu JS; Chiang WF
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1569-78. PubMed ID: 24859869
[TBL] [Abstract][Full Text] [Related]
13. The clinicopathologic significance of the expression of HLA-G in oral squamous cell carcinoma.
Gonçalves AS; Wastowski IJ; Capeletti LR; Sacono NT; Cortez AP; Valadares MC; Silva TA; Batista AC
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):361-8. PubMed ID: 24528793
[TBL] [Abstract][Full Text] [Related]
14. Salivary and serum interleukin 6 and basic fibroblast growth factor levels in patients with oral squamous cell carcinoma.
Vucicević Boras V; Cikes N; Lukać J; Virag M; Cekić-Arambasin A
Minerva Stomatol; 2005 Oct; 54(10):569-73. PubMed ID: 16224376
[TBL] [Abstract][Full Text] [Related]
15. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma.
G D; Nandan SRK; Kulkarni PG
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2087-2093. PubMed ID: 31350970
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of immunosuppressive cytokines is associated with poorer clinical stage of oral squamous cell carcinoma.
Arantes DA; Costa NL; Mendonça EF; Silva TA; Batista AC
Arch Oral Biol; 2016 Jan; 61():28-35. PubMed ID: 26513679
[TBL] [Abstract][Full Text] [Related]
17. S100A8 as potential salivary biomarker of oral squamous cell carcinoma using nanoLC-MS/MS.
Jou YJ; Hua CH; Lin CD; Lai CH; Huang SH; Tsai MH; Kao JY; Lin CW
Clin Chim Acta; 2014 Sep; 436():121-9. PubMed ID: 24863804
[TBL] [Abstract][Full Text] [Related]
18. High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients.
Chen CJ; Sung WW; Su TC; Chen MK; Wu PR; Yeh KT; Ko JL; Lee H
Clin Chim Acta; 2013 Jan; 415():25-30. PubMed ID: 22981868
[TBL] [Abstract][Full Text] [Related]
19. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
20. Possible association between TGF-β1 polymorphism and oral cancer.
Carneiro NK; Oda JM; Losi Guembarovski R; Ramos G; Oliveira BV; Cavalli IJ; de S F Ribeiro EM; Gonçalves MS; Watanabe MA
Int J Immunogenet; 2013 Aug; 40(4):292-8. PubMed ID: 23442056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
